MOLECULIN BIOTECH INC (MBRX:NASDAQ)
$8.745 -0.52 (-5.6125%)
Analysed MOLECULIN BIOTECH INC (MBRX:NASDAQ) News Sources
Moleculin Announces Pricing of $9.3 Million Public Offering
31-07-2026
yahoo.com
Moleculin Biotech (MBRX) Upgraded to Buy: Here's Why
24-08-2026
yahoo.com
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
27-08-2026
yahoo.com
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
11-09-2026
yahoo.com
Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings
14-09-2026
yahoo.com
Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040
23-09-2026
yahoo.com
Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
25-09-2026
yahoo.com
Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
29-09-2026
yahoo.com
Moleculin Announces Reverse Stock Split
16-10-2026
yahoo.com
Moleculin Releases Next CEO Corner Segment Highlighting Recent Progress in Annamycin MIRACLE Trial
20-10-2026
yahoo.com
What is the current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ)?
The current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ) is $8.745.
MOLECULIN BIOTECH INC (MBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is $-0.52.
MOLECULIN BIOTECH INC (MBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is -5.6125%.
What is the most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?
The most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?
The most recent sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is .
SEC-8K** Filing Available For MOLECULIN BIOTECH INC (MBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.